News for Healthier Living

Dual Targeting Approach Improves Immunotherapy Response in Glioblastoma

* Glioblastoma is a deadly brain cancer that doesn't respond well to immunotherapy * Blocking two key "don't eat me" signals at the same time improved response to immunotherapy in glioblastoma models * Targeting immune "first responders" is a promising strategy to improve antitumor response

March 12, 2026


March 16 2026

March 15 2026

March 14 2026

March 13 2026

March 12 2026

March 11 2026

March 10 2026

March 9 2026

March 8 2026

March 7 2026

March 6 2026

March 5 2026

March 4 2026

March 3 2026

March 2 2026